Gaurav Gupta, M.D., M.S.E., is Managing Partner of Life Science Private Capital (“LSPC”) within J.P. Morgan Private Capital, a division of J.P. Morgan Global Alternatives in J.P. Morgan Asset Management.

Gaurav joined J.P. Morgan Private Capital in 2022. Prior to joining LSPC, Gaurav was the founder of Ascendant BioCapital, and was previously an investment professional at OrbiMed Advisors. Gaurav served as a resident in neurological surgery at Columbia University Medical Center, where he completed post-doctoral research at the Institute for Cancer Genomics. He has co-authored over a dozen articles in peer-reviewed journals, been awarded patents on a novel therapeutic for the prevention of atherogenesis and a device for use in spine surgery, and edited a book on the technical and ethical implications of using tissue engineered products in the operating room.

Gaurav obtained his M.D. from the Stanford University School of Medicine where he was a recipient of the Paul and Daisy Soros Fellowship, and B.S. and M.S. in biomedical engineering from Johns Hopkins University, where he was a Charles R. Westgate Scholar.